Renalytix Plc
RENX.L · LSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £13,082 | £11,309 | £14,260 | £38,873 |
| - Cash | £9,209 | £909 | £4,680 | £4,704 |
| + Debt | £8,205 | £8,253 | £8,535 | £9,419 |
| Enterprise Value | £12,078 | £18,653 | £18,115 | £43,588 |
| Revenue | £729 | £522 | £586 | £535 |
| % Growth | 39.7% | -10.9% | 9.5% | – |
| Gross Profit | £398 | £100 | £36 | -£66 |
| % Margin | 54.6% | 19.2% | 6.1% | -12.3% |
| EBITDA | -£7,502 | -£4,032 | -£5,465 | -£6,067 |
| % Margin | -1,029.1% | -772.4% | -932.6% | -1,134% |
| Net Income | -£3,882 | -£4,728 | -£7,074 | -£7,743 |
| % Margin | -532.5% | -905.7% | -1,207.2% | -1,447.3% |
| EPS Diluted | -0.04 | -0.045 | -0.051 | -0.079 |
| % Growth | 10.7% | 12.7% | 35.4% | – |
| Operating Cash Flow | -£6,497 | -£3,836 | -£7,826 | -£4,862 |
| Capital Expenditures | £0 | £0 | -£1 | -£3 |
| Free Cash Flow | -£6,497 | -£3,836 | -£7,827 | -£4,865 |